Vetpharma Limited, headquartered in India, is a prominent player in the veterinary pharmaceutical industry, specialising in the development and distribution of innovative animal health products. Founded in 2005, the company has established a strong presence across major operational regions, including Asia and Europe, focusing on enhancing the well-being of livestock and companion animals. With a diverse portfolio that includes vaccines, anti-infectives, and nutritional supplements, Vetpharma Limited is recognised for its commitment to quality and efficacy. The company’s unique formulations and advanced delivery systems set it apart in a competitive market. Over the years, Vetpharma has achieved significant milestones, solidifying its position as a trusted partner for veterinarians and animal health professionals worldwide.
How does Vetpharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vetpharma Limited's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Vetpharma Limited does not report any specific carbon emissions figures, indicating a lack of disclosed emissions data. Consequently, there are no recorded Scope 1, 2, or 3 emissions figures to analyse. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a limited commitment to formal climate initiatives at this time. In the context of the industry, it is essential for companies like Vetpharma Limited to engage in climate action and transparency, particularly as stakeholders increasingly demand accountability regarding carbon footprints and sustainability practices. Without specific emissions data or reduction commitments, Vetpharma Limited may face challenges in aligning with industry standards and expectations for climate responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vetpharma Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

